TWIST1 and renal cell carcinoma: Similarly, Harmine [33, 34], which is a TWIST1 inhibitor through its degradation at the protein level (Fig. 2g), could dramatically block the effect of overexpressing AR on VM formation of RCC cells (Fig. 2h–i).